Surgery Partners (SGRY) Long-Term Deferred Tax (2015 - 2024)

Surgery Partners has disclosed Long-Term Deferred Tax across 10 years of filings, most recently posting $79.2 million for Q3 2024.

• Long-Term Deferred Tax for Q3 2024 came in at $79.2 million, down 24.57% year-over-year; the trailing twelve-month figure through Sep 2024 was $79.2 million (down 24.57% YoY), and the FY2023 annual result was $89.5 million, down 2.19% from the prior year.
• Long-Term Deferred Tax came in at $79.2 million for Q3 2024 at Surgery Partners, down from $81.8 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $129.8 million in Q2 2021 to a low of $79.2 million in Q3 2024.
• The 5-year median for Long-Term Deferred Tax is $105.7 million (2023), against an average of $106.3 million.
• Across the five-year window, Long-Term Deferred Tax grew 26.44% in 2020 and slipped 24.57% in 2024, its largest moves.
• Surgery Partners' Long-Term Deferred Tax stood at $124.8 million in 2020, then dropped by 8.33% to $114.4 million in 2021, then slipped by 20.02% to $91.5 million in 2022, then fell by 2.19% to $89.5 million in 2023, then decreased by 11.51% to $79.2 million in 2024.
• The last three Long-Term Deferred Tax figures came in at $79.2 million (Q3 2024), $81.8 million (Q2 2024), and $87.0 million (Q1 2024), per Business Quant data.